Trustmark National Bank Trust Department Novartis Ag Transaction History
Trustmark National Bank Trust Department
- $1.34 Billion
- Q4 2024
A detailed history of Trustmark National Bank Trust Department transactions in Novartis Ag stock. As of the latest transaction made, Trustmark National Bank Trust Department holds 55,204 shares of NVS stock, worth $6.19 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
55,204
Previous 65,017
15.09%
Holding current value
$6.19 Million
Previous $7.48 Million
28.18%
% of portfolio
0.4%
Previous 0.57%
Shares
14 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$918 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$770 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$625 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...